Conmed's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Conmed in the second quarter 2026?
Conmed Corporation achieved a return on average equity (ROE) of 5.51 % in its second quarter 2026, this is above CNMD's average return on equity of 4.75%.
Conmed Corporation shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $1,025 million

ROE has advanced compared to 5.4% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 50 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1267 to 1944.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	3.84 %	4.1 %	7.31 %	8.08 %	-
Y / Y Net Income Change	7.7 %	129.09 %	-50.41 %	-94.16 %	-28.54 %
Net Income (TTM) in Millions	56	55	47	64	110
Return On Equity (TTM)	5.51 %	5.4 %	4.68 %	6.49 %	11.37 %
CNMD's Total Ranking	# 1944	# 1267	# 1474	# 934	# 1014
Equity (TTM) in Millions	1,041	1,018	1,033	1,008	1,003
Seq. Equity Change	2.33 %	-1.49 %	2.46 %	0.54 %	2.58 %
Seq. Net Income Change	66.84 %	-17.39 %	485.48 %	-86.65 %	254.89 %

Back to CNMD Management Effectiveness >> CNMD's 5 Years Annual ROE >> Compare CNMD ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 51
Sector	# 165
Overall	# 1944

Return On Equity Statistics
High	Average	Low
15.04 %	4.75 %	-15.17 %
(Sep 30 2024)		(Jun 30 2022)

CNMD Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,033	963	834	746	785
Y / Y Equity Change	7.31 %	15.4 %	11.89 %	-5.08 %	10.77 %
Net Income in Millions	47	132	64	-81	63
Y / Y Net Income Change	-64.47 %	105.44 %	-	-	557.16 %
Return On Equity	4.55 %	13.76 %	7.73 %	-10.81 %	7.96 %

Back to CNMD Management Effectiveness >> CNMD's 5 Years Annual ROE >> Compare CNMD ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 4.55 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CNMD's' Return on Equity at Yahoo Finance
CNMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CNMD's Competitors
Subscribers only: Roe for Conmed's Suppliers
Subscribers only: Return On Equity for CNMD's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Lifevantage Corp	15.06 %
Quest Diagnostics Inc	14.85 %
Infusystem Holdings Inc	14.81 %
Boston Scientific Corporation	14.77 %
Strata Critical Medical Inc	14.27 %
Beone Medicines Ltd	14.24 %
Royalty Pharma Plc	13.82 %
Regeneron Pharmaceuticals Inc	13.81 %
National Healthcare Corp	13.11 %
Kewaunee Scientific Corporation	12.61 %
Protagonist Therapeutics inc	11.80 %
Entrada Therapeutics Inc	11.77 %
Haemonetics Corporation	11.66 %
Globus Medical Inc	11.59 %
Labcorp Holdings Inc	11.58 %
Tactile Systems Technology Inc	11.49 %
Nature s Sunshine Products inc	11.26 %
Penumbra Inc	11.09 %
Henry Schein Inc	10.88 %
Cadre Holdings inc	10.76 %
Medtronic Plc	10.64 %
Viemed Healthcare Inc	10.53 %
U S Physical Therapy Inc	10.50 %
The Pennant Group Inc	10.18 %
Amphastar Pharmaceuticals Inc	10.11 %
Align Technology inc	10.09 %
Ardent Health Inc	9.92 %
Edwards Lifesciences Corporation	9.65 %
Addus Homecare Corp	9.57 %
IMPACT BIOMEDICAL INC.	9.56 %

Date modified: 2026-08-13T05:53:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.